Using data science to forecast clinical trial outcomes
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
An analysis of executives at FTSE-listed companies and more than 322,000 UK Biobank participants finds lower leadership attainment among ethnic Chinese men.
Businesses have identified two types of generative AI: broadly applicable tools that boost personal productivity, and tailored solutions for specific purposes.